PRPO:NASDAQPrecipio, Inc. Analysis
Data as of 2026-05-19 - not real-time
$24.68
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Precipio, Inc. (PRPO) is trading above its short‑term moving average but still below the long‑term trend line, with the 14‑day RSI hovering in the mid‑30s and a bearish MACD crossover, suggesting limited upside momentum in the near term. Volume is on a downward trajectory, and price is approaching a clear support level near the lower end of its recent range.
Fundamentally, the company reports strong revenue growth exceeding 20% year‑over‑year, yet profitability remains negative with a trailing loss per share and a forward PE that is more than double the industry average. The discounted cash flow model values the stock at roughly $3, far below the current market price, indicating a significant overvaluation. Recent material announcements about 2025 employment plans and financial results provide limited catalyst potential, while the lack of dividend underscores the growth‑oriented, cash‑burn profile.
Fundamentally, the company reports strong revenue growth exceeding 20% year‑over‑year, yet profitability remains negative with a trailing loss per share and a forward PE that is more than double the industry average. The discounted cash flow model values the stock at roughly $3, far below the current market price, indicating a significant overvaluation. Recent material announcements about 2025 employment plans and financial results provide limited catalyst potential, while the lack of dividend underscores the growth‑oriented, cash‑burn profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support with bearish MACD
- Decreasing volume indicating waning buying pressure
- Negative earnings and high forward PE
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Strong revenue growth but persistent losses
- Valuation gap between market price and DCF fair value
- Limited near‑term catalysts from recent disclosures
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Severe overvaluation relative to cash‑flow fundamentals
- Negative profitability metrics (ROE, ROA) and high drawdown risk
- Sector exposure to regulatory and reimbursement uncertainty
Key Metrics & Analysis
Financial Health
Revenue Growth22.90%
Profit Margin-1.51%
P/E Ratio63.3
ROE-2.72%
ROA-3.92%
Debt/Equity25.09
P/B Ratio3.0
Op. Cash Flow$685.0K
Free Cash Flow$210.1K
Industry P/E27.2
Technical Analysis
TrendBullish
RSI36.7
Support$23.97
Resistance$33.63
MA 20$28.97
MA 50$27.95
MA 200$22.72
MACDBearish
VolumeDecreasing
Fear & Greed Index89.18
Valuation
Fair Value$3.28
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.28
Volatility69.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.